Calidi Biotherapeutics, Inc. (CLDI)
NYSEAMERICAN: CLDI · Real-Time Price · USD
0.224
-0.014 (-5.68%)
At close: Apr 28, 2026, 4:00 PM EDT
0.207
-0.017 (-7.77%)
Pre-market: Apr 29, 2026, 7:15 AM EDT
Calidi Biotherapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 2 | 9 | 22 | 54 | 100 | 282 | |
| Market Cap Growth | -83.26% | -61.46% | -58.52% | -46.69% | -64.38% | - | |
| Enterprise Value | -1 | 2 | 30 | 53 | - | - | |
| Last Close Price | 0.22 | 1.17 | 13.80 | 181.21 | 1220.45 | 1177.25 | |
| PS Ratio | - | - | - | - | 2232.42 | 628.14 | |
| PB Ratio | 0.44 | 2.28 | 11.29 | -6.50 | -2.46 | -12.47 | |
| P/TBV Ratio | 0.66 | 2.28 | 14.48 | - | - | - | |
| Debt / Equity Ratio | 0.68 | 0.68 | 3.58 | -0.88 | -0.15 | -0.23 | |
| Net Debt / Equity Ratio | -0.81 | -0.81 | -1.30 | -0.64 | -0.14 | -0.13 | |
| Net Debt / EBITDA Ratio | 0.16 | 0.16 | 0.13 | -0.18 | -0.25 | -0.32 | |
| Net Debt / FCF Ratio | 0.14 | 0.14 | 0.13 | -0.19 | -0.41 | -0.38 | |
| Asset Turnover | - | - | - | - | 0.02 | 0.17 | |
| Quick Ratio | 1.42 | 1.42 | 1.01 | 0.32 | 0.01 | 0.08 | |
| Current Ratio | 1.59 | 1.59 | 1.08 | 0.42 | 0.02 | 0.11 | |
| Return on Equity (ROE) | -700.65% | -700.65% | - | - | - | - | |
| Return on Assets (ROA) | -109.81% | -109.81% | -112.47% | -287.25% | -482.80% | -229.02% | |
| Return on Capital Employed (ROCE) | -411.20% | -411.20% | -464.70% | 13611.30% | 57.30% | 42.60% | |
| Earnings Yield | -1033.81% | -232.50% | -99.68% | -54.56% | -25.31% | -3.88% | |
| FCF Yield | -865.44% | -250.10% | -88.73% | -51.48% | -13.58% | -2.83% | |
| Buyback Yield / Dilution | -544.98% | -544.98% | -374.75% | -98.24% | 56.93% | -15.26% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.